A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
Instituto do Cancer do Estado de São Paulo
Klus Pharma Inc.
Theratechnologies
University Health Network, Toronto
Cybrexa Therapeutics
Carisma Therapeutics Inc
Salubris Biotherapeutics Inc